6-(chloromethyl)-N-thiazol-2-ylpyridin-2-amine | 885325-74-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 6-(chloromethyl)-N-thiazol-2-ylpyridin-2-amine
• 英文别名: N-[6-(chloromethyl)pyridin-2-yl]-1,3-thiazol-2-amine
• CAS: 885325-74-6
• 化学式: C₉H₈ClN₃S
• 分子量: 225.702
• InChiKey: CASSVQKSPDYUTF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-(chloromethyl)-N-thiazol-2-ylpyridin-2-amine 、 1-(3-chloro-2-fluorobenzoyl)piperazine 以 N,N-二甲基甲酰胺 为溶剂， 以obtained in Reference Example 1, 6.25 ml of N,N-diisopropylethylamine and 30 ml of dimethylformamide的产率得到N,N-二异丙基乙胺
  参考文献：
  名称：

  Novel aminopyridine derivatives having aurora a selective inhibitory action

  摘要：

  本发明涉及一种由通式（I）表示的化合物：其中m1和m2为1、2或3；n1和n2为0或1；i为1到m1中的任意整数；j为1到m2中的任意整数；R为取代的芳基、杂环芳基或环烷基；Rai和Rai′为氢原子等；Rbj和Rbj′为氢原子等；Rc、Rd和Re为氢原子等；X1为CH、CX1a或N；X2为CH、N等；X3为CH、N等；X4为CH或N；Y1、Y2和Y3分别独立地为CH或N；Z1和Z2分别独立地为CH或N；W为5-成员芳香杂环基，如吡唑基、噻唑基等，或其药学上可接受的盐或酯；包含该化合物的制药组合物或抗肿瘤剂；以及该抗肿瘤剂与其他抗肿瘤剂的组合物。

  公开号：

  US20090149470A1
• 作为产物：
  描述：

  (6-(thiazol-2-ylamino)pyridin-2-yl)methanol 在 氯化亚砜 作用下， 以 氯仿 为溶剂， 反应 2.0h， 生成 6-(chloromethyl)-N-thiazol-2-ylpyridin-2-amine
  参考文献：
  名称：

  WO2006/46735

  摘要：

  公开号：

文献信息

• Novel aminopyridine derivatives having aurora a selective inhibitory action
  申请人：Ohkubo Mitsuru

  公开号：US20060106029A1

  公开（公告）日：2006-05-18

  The present invention relates to a compound represented by the general formula (I): wherein m 1 and m 2 are 1, 2, or 3; n 1 and n 2 are 0 or 1; i is an integer of any of 1 to m 1 ; j is an integer of 1 to m 2 ; R is aryl, heteroaryl, or cycloalkyl any of which may be substituted; R ai and R ai ′ is hydrogen atom, etc. and R bj and R bj ′ is hydrogen atom, etc.; R c , R d , and R e are hydrogen atom, etc; X 1 is CH, CX 1a , or N; X 2 is CH, N, etc.; X 3 is CH, N, etc.; X 4 is CH or N; Y 1 , Y 2 , and Y 3 are each independently CH or N; Z 1 and Z 2 are each independently CH or N; W is a 5-membered aromatic heterocyclic group such as pyrazolyl, thiazolyl, etc., or a pharmaceutically acceptable salt or ester thereof; a pharmaceutical composition or antitumor agent containing the same; and combinations of the antitumor agent with other antitumor agent(s).

  本发明涉及一种由通式（I）表示的化合物：其中m1和m2为1、2或3；n1和n2为0或1；i为1到m1的任意整数；j为1到m2的任意整数；R为芳基、杂环芳基或环烷基，其中任何一个都可以被取代；Rai和Rai′为氢原子等；Rbj和Rbj′为氢原子等；Rc、Rd和Re为氢原子等；X1为CH、CX1a或N；X2为CH、N等；X3为CH、N等；X4为CH或N；Y1、Y2和Y3分别独立地为CH或N；Z1和Z2分别独立地为CH或N；W为5元芳香杂环基，例如咪唑基、噻唑基等，或其药学上可接受的盐或酯；一种含有该化合物的药物组合物或抗肿瘤剂；以及该抗肿瘤剂与其他抗肿瘤剂的组合。
• Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action
  申请人：Ohkubo Mitsuru

  公开号：US20080027042A1

  公开（公告）日：2008-01-31

  The present invention relates to a compound represented by the general formula (I): wherein m 1 and m 2 are 1, 2, or 3; n 1 and n 2 are 0 or 1; i is an integer of any of 1 to m 1 ; j is an integer of 1 to m 2 ; R is aryl, heteroaryl, or cycloalkyl any of which may be substituted; R ai and R ai ′ is hydrogen atom, etc. and R bj and R bj ′ is hydrogen atom, etc.; R c , R d , and R e are hydrogen atom, etc; X 1 is CH, CX 1a , or N; X 2 is CH, N, etc.; X 3 is CH, N, etc.; X 4 is CH or N; Y 1 , Y 2 , and Y 3 are each independently CH or N; Z 1 and Z 2 are each independently CH or N; W is a 5-membered aromatic heterocyclic group such as pyrazolyl, thiazolyl, etc., or a pharmaceutically acceptable salt or ester thereof; a pharmaceutical composition or antitumor agent containing the same; and combinations of the antitumor agent with other antitumor agent(s).

  本发明涉及一种由通式（I）表示的化合物：其中m1和m2为1、2或3；n1和n2为0或1；i为1到m1的任意整数；j为1到m2的任意整数；R为芳基、杂环芳基或环烷基，其中任何一个都可以被取代；Rai和Rai′为氢原子等；Rbj和Rbj′为氢原子等；Rc、Rd和Re为氢原子等；X1为CH、CX1a或N；X2为CH、N等；X3为CH、N等；X4为CH或N；Y1、Y2和Y3分别独立为CH或N；Z1和Z2分别独立为CH或N；W为5-成员芳香杂环基，例如吡唑基、噻唑基等，或其药学上可接受的盐或酯；以及含有该化合物的药物组合物或抗肿瘤剂；以及与其他抗肿瘤剂的组合使用。
• Aminopyridine derivatives having Aurora A selective inhibitory action
  申请人：Banyu Pharmaceutical Co., Ltd.

  公开号：US07491720B2

  公开（公告）日：2009-02-17

  The present invention relates to a compound represented by the general formula (I): wherein m1 and m2 are 1, 2, or 3; n1 and n2 are 0 or 1; i is an integer of any of 1 to m1; j is an integer of 1 to m2; R is aryl, heteroaryl, or cycloalkyl any of which may be substituted; Rai and Rai′ is hydrogen atom, etc. and Rbj and Rbj′ is hydrogen atom, etc.; Rc, Rd, and Re are hydrogen atom, etc; X1 is CH, CX1a, or N; X2 is CH, N, etc.; X3 is CH, N, etc.; X4 is CH or N; Y1, Y2, and Y3 are each independently CH or N; Z1 and Z2 are each independently CH or N; W is a 5-membered aromatic heterocyclic group such as pyrazolyl, thiazolyl, etc., or a pharmaceutically acceptable salt or ester thereof; a pharmaceutical composition or antitumor agent containing the same; and combinations of the antitumor agent with other antitumor agent(s).

  本发明涉及一种由通式(I)表示的化合物：其中m1和m2为1、2或3；n1和n2为0或1；i为1到m1的任意整数；j为1到m2的任意整数；R为芳基、杂环芳基或环烷基，其中任何一种可能被取代；Rai和Rai′为氢原子等；Rbj和Rbj′为氢原子等；Rc、Rd和Re为氢原子等；X1为CH、CX1a或N；X2为CH、N等；X3为CH、N等；X4为CH或N；Y1、Y2和Y3各自独立地为CH或N；Z1和Z2各自独立地为CH或N；W为5-成员芳香杂环基，例如吡唑基、噻唑基等，或其药学上可接受的盐或酯；包含该化合物的制药组合物或抗肿瘤剂；以及该抗肿瘤剂与其他抗肿瘤剂的组合。
• NOVEL AMINOPYRIDINE DERIVATIVES HAVING SELECTIVE AURORA-A INHIBITORY EFFECT
  申请人：MSD K.K.

  公开号：EP1813609B1

  公开（公告）日：2013-06-19
• NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP1828165A1

  公开（公告）日：2007-09-05